Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Low Extrem Wounds ; : 15347346241262061, 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38887078

ABSTRACT

Diabetic Foot Syndrome is a complex and challenging clinical condition associated with high risk of mortality and lower limb amputation. The distal lesions represent the epiphenomenon of this syndrome and request a multidisciplinary care and an appropriate therapeutic path to ensure their healing. This case report describes the management of burns in a patient with type 2 diabetes mellitus, end stage renal disease and Diabetic Foot Syndrome. The lesions were treated with autologous epidermal skin graft until healing. Products that stimulate or replace extracellular matrix, which has a central role in wound healing, can be consider in the treatment of burns and offer a simpler and less disabling reconstructive possibility for the patient.

2.
Ital Heart J ; 6(1): 28-34, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15773270

ABSTRACT

BACKGROUND: The potential benefits of direct percutaneous transluminal coronary angioplasty (PTCA) on malignant arrhythmias in the hospital phase of acute myocardial infarction have not yet been established. METHODS: We prospectively investigated the incidence and timing of major arrhythmias occurring during direct PTCA and within 24 hours of mechanical reperfusion in 90 consecutive patients with acute myocardial infarction undergoing successful direct PTCA within 12 hours of symptom onset. RESULTS: Ventricular fibrillation and complete atrioventricular block occurred exclusively during direct PTCA and both resolved in the catheterization laboratory. Holter monitoring showed that ventricular tachyarrhythmias, such as runs of more than 3 extrasystoles, were detectable only during the first 8 hours after direct PTCA. CONCLUSIONS: In our group of patients undergoing successful direct PTCA, no in-hospital life-threatening arrhythmias occurred after this procedure.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Heart Block/etiology , Myocardial Infarction/therapy , Ventricular Fibrillation/etiology , Analysis of Variance , Electrocardiography, Ambulatory , Female , Follow-Up Studies , Heart Block/physiopathology , Heart Rate/physiology , Humans , Incidence , Male , Middle Aged , Prospective Studies , Time Factors , Ventricular Fibrillation/physiopathology
3.
Ital Heart J ; 5(7): 536-40, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15487272

ABSTRACT

BACKGROUND: Paclitaxel-eluting stents (PES) have been proven to prevent in-stent restenosis in patients submitted to elective percutaneous coronary intervention. No data are so far available about the safety and efficacy of PES in acute and subacute myocardial infarction. The aim of the present investigation was to evaluate the occurrence of in-hospital adverse events in patients with acute and subacute myocardial infarction submitted to PES implantation. METHODS: From June 1 to July 31, 2003, we implanted 53 PES in 43 consecutive patients with acute (34 patients) and subacute (9 patients) myocardial infarction. RESULTS: In 65.1% of the patients the culprit lesion was located in the left anterior descending artery. Direct stenting was performed in 27.9% and glycoprotein IIb/IIIa inhibitors were used in 74.4%. Before the procedure a TIMI flow 0-1 was present in 46.5% while post-procedural TIMI flow 3 was achieved in all patients. A pre-procedural TIMI thrombus grade 2 to 5 was present in 67.8%. No death, reinfarction, early post-infarction angina or any other episode referable to in-stent thrombosis were observed during hospitalization. No patient was submitted to target lesion revascularization. At short-term follow-up with a mean duration of 118 +/- 75 days from discharge no cardiac or noncardiac death, reinfarction or any other major adverse coronary events were reported in the study population and no target lesion revascularization was performed. CONCLUSIONS: In this study, PES implant in patients with acute and subacute myocardial infarction was safe, with an early outcome comparable to conventional standard stents and no adverse events related to acute or subacute thrombosis.


Subject(s)
Angioplasty, Balloon, Coronary/adverse effects , Coronary Restenosis/diagnosis , Myocardial Infarction/diagnosis , Myocardial Infarction/therapy , Paclitaxel/pharmacology , Stents , Age Distribution , Aged , Angioplasty, Balloon, Coronary/methods , Coated Materials, Biocompatible , Coronary Angiography/methods , Coronary Restenosis/epidemiology , Electrocardiography/methods , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Myocardial Infarction/mortality , Prospective Studies , Risk Assessment , Severity of Illness Index , Sex Distribution , Survival Analysis , Treatment Outcome
4.
Ital Heart J ; 5(6): 470-4, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15320574

ABSTRACT

Recent studies with eluting stents showed encouraging results in preventing in-stent restenosis. We report a case of a patient in whom the implantation of carbon-coated and eluting stents in two different vessels was associated with different angiographic results. A diabetic hypertensive 67-year-old woman with an acute inferior myocardial infarction underwent direct coronary angioplasty on the right coronary artery with the implantation of two carbon-coated stents. In view of the severity of an additional lesion of the left anterior descending coronary artery and diabetes, coronary angioplasty and stenting with an eluting stent was performed in this vessel. Five months later the patient presented with acute pulmonary edema and an increase in troponin I levels. A new coronary angiography showed a long subtotal in-stent restenosis of the right coronary artery, whereas the left anterior descending coronary artery was normal. Our case report suggests that eluting stents should be considered a precious and effective tool in preventing in-stent restenosis.


Subject(s)
Coronary Stenosis/prevention & control , Myocardial Infarction/therapy , Sirolimus/administration & dosage , Stents , Aged , Angioplasty , Carbon , Coated Materials, Biocompatible , Coronary Angiography , Diabetes Mellitus, Type 1/complications , Female , Humans , Hypertension/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...